Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Olga A. Kondakova, Nikolai A. Nikitin, Ekaterina A. Evtushenko, Ekaterina M. Ryabchevskaya, Joseph G. Atabekov & Olga V. Karpova. (2019) Vaccines against anthrax based on recombinant protective antigen: problems and solutions. Expert Review of Vaccines 18:8, pages 813-828.
Read now
Read now
Dimitrios G Bouzianas. (2007) Potential biological targets of Bacillus anthracis in anti-infective approaches against the threat of bioterrorism. Expert Review of Anti-infective Therapy 5:4, pages 665-684.
Read now
Read now
Articles from other publishers (24)
Muhammad Ajmal Khan, Aftab Amin, Awais Farid, Amin Ullah, Abdul Waris, Khyber Shinwari, Yaseen Hussain, Khalaf F. Alsharif, Khalid J. Alzahrani & Haroon Khan. (2022) Recent Advances in Genomics-Based Approaches for the Development of Intracellular Bacterial Pathogen Vaccines. Pharmaceutics 15:1, pages 152.
Crossref
Crossref
Anke Osterloh. (2022) Vaccination against Bacterial Infections: Challenges, Progress, and New Approaches with a Focus on Intracellular Bacteria. Vaccines 10:5, pages 751.
Crossref
Crossref
Marcin Michalik, Bardya Djahanschiri, Jack C. Leo & Dirk Linke. 2022. Vaccine Design. Vaccine Design
45
71
.
Anshul Varshney, Manoj Kumar, D.P. Nagar, Vijai Pal & A.K. Goel. (2019) Development of a novel chimeric PA-LF antigen of Bacillus anthracis, its immunological characterization and evaluation as a future vaccine candidate in mouse model. Biologicals 61, pages 38-43.
Crossref
Crossref
N. I. Mikshis, P. Yu. Popova, A. P. Semakova & V. V. Kutyrev. (2017) LICENSED ANTHRAX VACCINES AND EXPERIMENTAL PREPARATIONS AT THE STAGE OF CLINICAL TRIALS. Journal of microbiology, epidemiology and immunobiology 94:4, pages 112-126.
Crossref
Crossref
Yuchen Fan & James J. Moon. (2016) Particulate delivery systems for vaccination against bioterrorism agents and emerging infectious pathogens. WIREs Nanomedicine and Nanobiotechnology 9:1.
Crossref
Crossref
Tarlan Mamedov, Jessica A. Chichester, R. Mark Jones, Ananya Ghosh, Megan V. Coffin, Kristina Herschbach, Alexey I. Prokhnevsky, Stephen J. Streatfield & Vidadi Yusibov. (2016) Production of Functionally Active and Immunogenic Non-Glycosylated Protective Antigen from Bacillus anthracis in Nicotiana benthamiana by Co-Expression with Peptide-N-Glycosidase F (PNGase F) of Flavobacterium meningosepticum. PLOS ONE 11:4, pages e0153956.
Crossref
Crossref
Marcin Michalik, Bardya Djahanshiri, Jack C. Leo & Dirk Linke. 2016. Vaccine Design. Vaccine Design
87
106
.
Mahtab MoayeriStephen H. LepplaCatherine VrentasAndrei P. PomerantsevShihui Liu. (2015) Anthrax Pathogenesis. Annual Review of Microbiology 69:1, pages 185-208.
Crossref
Crossref
Shipo Wu, Zhe Zhang, Rui Yu, Jun Zhang, Ying Liu, Xiaohong Song, Shaoqiong Yi, Ju Liu, Jianqin Chen, Ying Yin, Junjie Xu, Lihua Hou & Wei Chen. (2014) Intramuscular Delivery of Adenovirus Serotype 5 Vector Expressing Humanized Protective Antigen Induces Rapid Protection against Anthrax That May Bypass Intranasally Originated Preexisting Adenovirus Immunity. Clinical and Vaccine Immunology 21:2, pages 156-164.
Crossref
Crossref
Sheena H. Wang, Shaun M. Kirwan, Soman N. Abraham, Herman F. Staats & Anthony J. Hickey. (2012) Stable Dry Powder Formulation for Nasal Delivery of Anthrax Vaccine. Journal of Pharmaceutical Sciences 101:1, pages 31-47.
Crossref
Crossref
Bruce K. Brown, Josephine Cox, Anita Gillis, Thomas C. VanCott, Mary Marovich, Mark Milazzo, Tanya Santelli Antonille, Lindsay Wieczorek, Kelly T. McKee, Karen Metcalfe, Raburn M. Mallory, Deborah Birx, Victoria R. Polonis & Merlin L. Robb. (2010) Phase I Study of Safety and Immunogenicity of an Escherichia coli-Derived Recombinant Protective Antigen (rPA) Vaccine to Prevent Anthrax in Adults. PLoS ONE 5:11, pages e13849.
Crossref
Crossref
Gaobing Wu, Yuzhi Hong, Aizhen Guo, Chunfang Feng, Sha Cao, Cheng-Cai Zhang, Ruiping Shi, Yadi Tan & Ziduo Liu. (2010) A Chimeric Protein That Functions as both an Anthrax Dual-Target Antitoxin and a Trivalent Vaccine. Antimicrobial Agents and Chemotherapy 54:11, pages 4750-4757.
Crossref
Crossref
Brian D. Livingston, Stephen F. Little, Alain Luxembourg, Barry Ellefsen & Drew Hannaman. (2010) Comparative performance of a licensed anthrax vaccine versus electroporation based delivery of a PA encoding DNA vaccine in rhesus macaques. Vaccine 28:4, pages 1056-1061.
Crossref
Crossref
Robert J. CybulskiJr.Jr., Patrick Sanz & Alison D. O’Brien. (2009) Anthrax vaccination strategies. Molecular Aspects of Medicine 30:6, pages 490-502.
Crossref
Crossref
Dimitrios G. Bouzianas. (2009) Medical countermeasures to protect humans from anthrax bioterrorism. Trends in Microbiology 17:11, pages 522-528.
Crossref
Crossref
Donald Reason, Justine Liberato, Jinying Sun, Wendy Keitel & Jianhui Zhou. (2009) Frequency and Domain Specificity of Toxin-Neutralizing Paratopes in the Human Antibody Response to Anthrax Vaccine Adsorbed. Infection and Immunity 77:5, pages 2030-2035.
Crossref
Crossref
Anette SchneemannMarianne Manchester. (2009) Anti-toxin antibodies in prophylaxis and treatment of inhalation anthrax. Future Microbiology 4:1, pages 35-43.
Crossref
Crossref
Donald C. Reason, Anuska Ullal, Justine Liberato, Jinying Sun, Wendy Keitel & Jianhui Zhou. (2008) Domain specificity of the human antibody response to Bacillus anthracis protective antigen. Vaccine 26:32, pages 4041-4047.
Crossref
Crossref
S. Plotkin & J. D. Grabenstein. (2008) Countering Anthrax: Vaccines and Immunoglobulins. Clinical Infectious Diseases 46:1, pages 129-136.
Crossref
Crossref
Yu-Tsueng Liu, Shwu-Bin Lin, Cheng-Po Huang & Chun-Ming Huang. (2008) A novel immunogenic spore coat-associated protein in Bacillus anthracis: Characterization via proteomics approaches and a vector-based vaccine system. Protein Expression and Purification 57:1, pages 72-80.
Crossref
Crossref
Philip S. Brachman, Arthur M. Friedlander & John D. Grabenstein. 2008. Vaccines. Vaccines
111
126
.
Valentina A. Feodorova & Onega V. Ulianova. 2008. National Institute of Allergy and Infectious Diseases, NIH. National Institute of Allergy and Infectious Diseases, NIH
241
248
.
Darly J Manayani, Diane Thomas, Kelly A Dryden, Vijay Reddy, Marc E Siladi, John M Marlett, G. Jonah A Rainey, Michael E Pique, Heather M Scobie, Mark Yeager, John A. T Young, Marianne Manchester & Anette Schneemann. (2007) A Viral Nanoparticle with Dual Function as an Anthrax Antitoxin and Vaccine. PLoS Pathogens 3:10, pages e142.
Crossref
Crossref